Sugi Predict

Sugi Predict / Compounds / SCHEMBL3565933

SCHEMBL3565933

SCHEMBL3565933

O=c1ccoc(CO)c1OCc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.64
▸ GAA P10253 1/20 0.64
▸ MAOB P27338 2/20 0.49
▸ MAOA P21397 1/20 0.48
▸ POLB P06746 1/20 0.46
▸ KCNA2 P16389 1/20 0.43
▸ KCNA5 P22460 1/20 0.43
▸ KCNA1 Q09470 1/20 0.43
▸ KMT2A Q03164 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ ALDH1A1 P00352 1/20 0.43
▸ KCNA3 P22001 1/20 0.42
▸ GSTP1 P09211 1/20 0.42
▸ CREB1 P16220 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL990135 0.85 LMNA (0.68) LMNAGAAMAOBMAOAPOLB
SCHEMBL18837908 0.85 LMNA (0.64) LMNAGAAMAOBMAOAPOLB
SCHEMBL6994111 0.84 LMNA (0.67) LMNAGAAMAOBMAOAPOLB
SCHEMBL12397417 0.82 LMNA (0.60) LMNAGAAMAOBMAOAPOLB
SCHEMBL3320803 0.81 GAA (0.59) LMNAGAAMAOBMAOAPOLB
SCHEMBL1785011 0.81 LMNA (0.56) LMNAGAAMAOBMAOAPOLB
SCHEMBL86223 0.79 LMNA (0.64) LMNAGAAMAOBMAOAPOLB
SCHEMBL81547 0.78 LMNA (1.00) LMNAGAAMAOBMAOAPOLB
SCHEMBL7622844 0.77 KDM4E (0.48) LMNAGAAPOLBKMT2AMEN1
SCHEMBL14129739 0.77 LMNA (0.61) LMNAGAAMAOBMAOAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109438405-B Synthetic method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid 广东莱佛士制药技术有限公司 2023-04-07 — — CN claimed
CN-109438405-B Synthetic method of 3- (benzyloxy) -4-oxo-4H-pyran-2-carboxylic acid 广东莱佛士制药技术有限公司 2023-04-07 — — CN disclosed
CN-111606879-A Method for preparing 2-hydroxymethyl-3-alkoxy-4H-pyran-4-ketone by one-pot method 安徽金禾实业股份有限公司 2020-09-01 — — CN disclosed
WO-2020132820-A1 SYNTHESIS METHOD FOR 3-(BENZYLOXY)-4-OXO-4H-PYRAN-2-CARBOXYLIC ACID 广东莱佛士制药技术有限公司 2020-07-02 — — WO disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-20170066754-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2017-03-09 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
US-9572813-B2 Antiviral agent SHIONOGI & CO., LTD. (JP) 2017-02-21 — — US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 — — US disclosed
US-20150202208-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2015-07-23 — — US disclosed
US-20040152698-A1 Heterocyclic carboxamides and their use as fungicides BAYER SAS (FR) 2004-08-05 — — US disclosed
EP-1425276-A2 HETEROCYCLIC CARBOXAMIDES AND THEIR USE AS FUNGICIDES Bayer CropScience S.A. (FR) 2004-06-09 — — EP disclosed
WO-2003006454-A2 HETEROCYCLIC CARBOXAMIDES AND THEIR USE AS FUNGICIDES BAYER CROPSCIENCE S.A. (FR) 2003-01-23 — — WO disclosed
US-6506911-B2 Reacting a 2-(1-hydroxyalkyl)-3-hydroxypyran-4(1H)one compound with benzaldehyde dimethyl acetal to form 8-oxo-4,8-dihydro-2-phenyl-4h(3,2-d)-m-dioxin, reacting it with an amine compound to form an intermediate, then reducing BTG INTERNATIONAL LIMITED (GB) 2003-01-14 — — US disclosed
EP-0984934-B1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNAT LTD COMPANY NO 26 (GB) 2003-01-08 — — EP disclosed
US-6448273-B1 SUCH AS 2,6-DIMETHOXYMETHYL-1-METHYL-3-BENZYLOXPYRIDIN-4(1H)-ONE; TREATING DISORDERS ASSOCIATED WITH IRON DISTRIBUTION AND IRON DEPENDANT PARASITES; REDUCED LEVELS OF ACTIVE AGENT; SELECTIVE TARGETING TO TISSUES AND LIVER; METABOLIC STABILITY BTG INTERNATIONAL LIMITED (GB) 2002-09-10 — — US disclosed
US-20020068758-A1 Novel orally active iron (III) chelators BTG INTERNATIONAL LIMITED. 2002-06-06 — — US disclosed
US-6335353-B1 3-HYDROXYPYRIDIN-4-ONE DERIVATIVE; IRON DEFICIENCY ANEMIA AND THALASSEMIA TREATMENT BTG INTERNATIONAL LIMITED (GB) 2002-01-01 — — US disclosed
EP-0984934-A1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNATIONAL LIMITED (Company No. 2664412) (GB) 2000-03-15 — — EP disclosed
WO-1998054138-A1 NOVEL ORALLY ACTIVE IRON (III) CHELATORS BTG INTERNATIONAL LIMITED (GB) 1998-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040152698-A1 Heterocyclic carboxamides and their use as fungicides CYP1A2, CYP4X1, CYCS LMNA 2402/4885GAA 319/4885MAOB 482/4885
US-20020068758-A1 Novel orally active iron (III) chelators HAMP, HRH2, GRHPR LMNA 2634/4885GAA 1367/4885MAOB 2587/4885
US-20150202208-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI LMNA 2945/4885GAA 1442/4885MAOB 900/4885
US-20170066754-A1 ANTIVIRAL AGENT ZC3HAV1, ZC3HAV1L, CCNI LMNA 2945/4885GAA 1442/4885MAOB 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.